MVCHX | VMVAX | MVCHX / VMVAX | |
Total Expense Ratio | 0.99 | 0.07 | 1,414% |
Annual Report Gross Expense Ratio | 1.00 | 0.07 | 1,429% |
Fund Existence | 20 years | 14 years | - |
Gain YTD | 3.835 | 5.532 | 69% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.3B | 30.6B | 57% |
Annual Yield % from dividends | 0.88 | 2.26 | 39% |
Returns for 1 year | -1.71 | 9.76 | -17% |
Returns for 3 years | 18.06 | 28.18 | 64% |
Returns for 5 years | 56.55 | 71.82 | 79% |
Returns for 10 years | 71.13 | 93.07 | 76% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
UCC | 48.05 | 0.79 | +1.68% |
ProShares Ultra Consumer Discretionary | |||
MYCL | 24.65 | 0.06 | +0.26% |
SPDR SSGA My2032 Corporate Bond ETF | |||
CGBL | 33.96 | 0.07 | +0.21% |
Capital Group Core Balanced ETF | |||
DVAL | 14.45 | 0.02 | +0.11% |
BrandywineGLOBAL Dyn US Lrg Cap Val ETF | |||
FYLD | 30.33 | -0.12 | -0.41% |
Cambria Foreign Shareholder Yield ETF |